No abstract available
MeSH terms
-
Alloys
-
Cardiovascular Agents / adverse effects*
-
Clinical Trials as Topic
-
Coronary Restenosis / prevention & control*
-
Drug-Eluting Stents / adverse effects*
-
Humans
-
Hypersensitivity / etiology*
-
Incidence
-
Paclitaxel / adverse effects
-
Platelet Aggregation Inhibitors / therapeutic use
-
Risk Factors
-
Sirolimus / adverse effects
-
Thrombosis / etiology*
-
Thrombosis / prevention & control
-
Time Factors
Substances
-
Alloys
-
Cardiovascular Agents
-
Platelet Aggregation Inhibitors
-
Paclitaxel
-
Sirolimus